Google plans to crack down on ads for bogus medical treatments, as the company has observed a rise in predatory scams that target desperate patients.

Quick Read

It’s launching their physicians into uncharted territory. Corner-store cannabidiol “scares the bejesus” out of Dr. Jacqueline French. French, a neurologist, tries to steer her patients away from sprinting to the neighborhood bodega to buy versions of the hemp derivative that’s better known as CBD

Quick Read

While these findings regarding professionalism are disturbing, they do point toward another way in which fraudulent stem cell clinics can be stopped, said Alan Regenberg, at the Johns Hopkins Berman Institute of Bioethics

Quick Read

In a decision expected to send a chill through the booming stem cell industry, a federal judge ruled in favor of the Food and Drug Administration on Monday in a lawsuit against a Florida-based stem cell company whose treatments have blinded at least four patients

Quick Read

ISSCR, an international stem-cell body says the country’s proposed law could put patients at risk

Quick Read

The FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints

Quick Read

How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

Under a draft proposal, patients would be able to buy some therapies without regulatory approval

Quick Read